165 related articles for article (PubMed ID: 15113609)
1. Effect of lactide/glycolide monomers on release behaviors of gentamicin sulfate-loaded PLGA discs.
Yoo JY; Kim JM; Khang G; Kim MS; Cho SH; Lee HB; Kim YS
Int J Pharm; 2004 May; 276(1-2):1-9. PubMed ID: 15113609
[TBL] [Abstract][Full Text] [Related]
2. Co-effect of aqueous solubility of drugs and glycolide monomer on in vitro release rates from poly(D,L-lactide-co-glycolide) discs and polymer degradation.
Kim JM; Seo KS; Jeong YK; Hai BL; Kim YS; Khang G
J Biomater Sci Polym Ed; 2005; 16(8):991-1007. PubMed ID: 16128233
[TBL] [Abstract][Full Text] [Related]
3. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions.
Liu SQ; Tong YW; Yang YY
Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542
[TBL] [Abstract][Full Text] [Related]
4. A protein/antibiotic releasing poly(lactic-co-glycolic acid)/lecithin scaffold for bone repair applications.
Shi X; Wang Y; Ren L; Huang W; Wang DA
Int J Pharm; 2009 May; 373(1-2):85-92. PubMed ID: 19429292
[TBL] [Abstract][Full Text] [Related]
5. Degradation behaviour in vitro for poly(D,L-lactide-co-glycolide) as drug carrier.
Lee JS; Chae GS; Kim MS; Cho SH; Lee HB; Khang G
Biomed Mater Eng; 2004; 14(2):185-92. PubMed ID: 15156109
[TBL] [Abstract][Full Text] [Related]
6. Enhanced gentamicin loading and release of PLGA and PLHMGA microspheres by varying the formulation parameters.
Chaisri W; Ghassemi AH; Hennink WE; Okonogi S
Colloids Surf B Biointerfaces; 2011 Jun; 84(2):508-14. PubMed ID: 21353499
[TBL] [Abstract][Full Text] [Related]
7. Development of a novel AMX-loaded PLGA/zein microsphere for root canal disinfection.
Sousa FF; Luzardo-Alvarez A; Pérez-Estévéz A; Seoane-Prado R; Blanco-Méndez J
Biomed Mater; 2010 Oct; 5(5):055008. PubMed ID: 20844319
[TBL] [Abstract][Full Text] [Related]
8. Gentamicin-loaded discs and microspheres and their modifications: characterization and in vitro release.
Naraharisetti PK; Lew MD; Fu YC; Lee DJ; Wang CH
J Control Release; 2005 Feb; 102(2):345-59. PubMed ID: 15653156
[TBL] [Abstract][Full Text] [Related]
9. The release of cefazolin and gentamicin from biodegradable PLA/PGA beads.
Wang G; Liu SJ; Ueng SW; Chan EC
Int J Pharm; 2004 Apr; 273(1-2):203-12. PubMed ID: 15010144
[TBL] [Abstract][Full Text] [Related]
10. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
[TBL] [Abstract][Full Text] [Related]
11. Gentamicin-loaded microspheres for reducing the intracellular Brucella abortus load in infected monocytes.
Prior S; Gander B; Lecároz C; Irache JM; Gamazo C
J Antimicrob Chemother; 2004 Jun; 53(6):981-8. PubMed ID: 15102748
[TBL] [Abstract][Full Text] [Related]
12. Controlled release of ethacrynic acid from poly(lactide-co-glycolide) films for glaucoma treatment.
Wang Y; Challa P; Epstein DL; Yuan F
Biomaterials; 2004 Aug; 25(18):4279-85. PubMed ID: 15046918
[TBL] [Abstract][Full Text] [Related]
13. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
[TBL] [Abstract][Full Text] [Related]
14. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM
J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles.
Dillen K; Vandervoort J; Van den Mooter G; Ludwig A
Int J Pharm; 2006 May; 314(1):72-82. PubMed ID: 16600538
[TBL] [Abstract][Full Text] [Related]
16. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.
Duvvuri S; Janoria KG; Mitra AK
J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919
[TBL] [Abstract][Full Text] [Related]
17. Improvement of gentamicin poly(D,L-lactic-co-glycolic acid) microspheres for treatment of osteomyelitis induced by orthopedic procedures.
Virto MR; Elorza B; Torrado S; Elorza Mde L; Frutos G
Biomaterials; 2007 Feb; 28(5):877-85. PubMed ID: 17064761
[TBL] [Abstract][Full Text] [Related]
18. Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres.
Janoria KG; Mitra AK
Int J Pharm; 2007 Jun; 338(1-2):133-41. PubMed ID: 17363204
[TBL] [Abstract][Full Text] [Related]
19. Controlled release of paclitaxel from microemulsion containing PLGA and evaluation of anti-tumor activity in vitro and in vivo.
Kang BK; Chon SK; Kim SH; Jeong SY; Kim MS; Cho SH; Lee HB; Khang G
Int J Pharm; 2004 Nov; 286(1-2):147-56. PubMed ID: 15501011
[TBL] [Abstract][Full Text] [Related]
20. Controlled delivery of aspirin: effect of aspirin on polymer degradation and in vitro release from PLGA based phase sensitive systems.
Tang Y; Singh J
Int J Pharm; 2008 Jun; 357(1-2):119-25. PubMed ID: 18329202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
